Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 BRAF mutation in metastatic colorectal cancer.

× No keyword cloud information.

208 in total

Review 1. Colorectal cancer molecular biology moves into clinical practice.

Authors: Colin C Pritchard; William M Grady
Journal: Gut Date: 2010-10-04 Impact factor: 23.059

2. HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.

Authors: David Liska; Chin-Tung Chen; Thomas Bachleitner-Hofmann; James G Christensen; Martin R Weiser
Journal: Clin Cancer Res Date: 2010-11-22 Impact factor: 12.531

3. A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.

Authors: Nan Soon Wong; Nishan H Fernando; Andrew B Nixon; Stephanie Cushman; Mebea Aklilu; Johanna C Bendell; Michael A Morse; Gerard C Blobe; Jill Ashton; Herbert Pang; Herbert I Hurwitz
Journal: Anticancer Res Date: 2011-01 Impact factor: 2.480

4. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications.

Authors: Frank A Sinicrope; Daniel J Sargent
Journal: Clin Cancer Res Date: 2012-02-02 Impact factor: 12.531

Review 5. BRAF mutant colorectal cancer as a distinct subset of colorectal cancer: clinical characteristics, clinical behavior, and response to targeted therapies.

Authors: Callisia N Clarke; E Scott Kopetz
Journal: J Gastrointest Oncol Date: 2015-12

Review 6. Genomic diversity of colorectal cancer: Changing landscape and emerging targets.

Authors: Daniel H Ahn; Kristen K Ciombor; Sameh Mikhail; Tanios Bekaii-Saab
Journal: World J Gastroenterol Date: 2016-07-07 Impact factor: 5.742

7. Prioritization in comparative effectiveness research: the CANCERGEN Experience.

Authors: Rahber Thariani; William Wong; Josh J Carlson; Louis Garrison; Scott Ramsey; Patricia A Deverka; Laura Esmail; Sneha Rangarao; Carolyn J Hoban; Laurence H Baker; David L Veenstra
Journal: Med Care Date: 2012-05 Impact factor: 2.983

8. PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancer.

Authors: Arjun Sood; Danielle McClain; Radhashree Maitra; Atrayee Basu-Mallick; Raviraja Seetharam; Andreas Kaubisch; Lakshmi Rajdev; John M Mariadason; Kathryn Tanaka; Sanjay Goel
Journal: Clin Colorectal Cancer Date: 2012-01-28 Impact factor: 4.481

Review 9. Genomic era diagnosis and management of hereditary and sporadic colon cancer.

Authors: Edward David Esplin; Michael Paul Snyder
Journal: World J Clin Oncol Date: 2014-12-10

10. Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agents.

Authors: Muling Mao; Feng Tian; John M Mariadason; Chun C Tsao; Robert Lemos; Farshid Dayyani; Y N Vashisht Gopal; Zhi-Qin Jiang; Ignacio I Wistuba; Xi M Tang; William G Bornman; Gideon Bollag; Gordon B Mills; Garth Powis; Jayesh Desai; Gary E Gallick; Michael A Davies; Scott Kopetz
Journal: Clin Cancer Res Date: 2012-12-18 Impact factor: 12.531